Redox biology of the intestine

Free Radical Research

Volumn 45, Issue 11-12, 2011, Pages 1245-1266

  Circu, Magdalena L ^a   Aw, Tak Yee ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Cellular glutathione glutathione disulfide (GSH GSSG) redox state; Extracellular cysteine cystine (Cys CySS) redox state; GSH and intestinal oxidative stress; Intestinal disorders and tissue redox state; Intestinal microbiota; Intestinal NF B redox signalling; Intestinal redox status and control of redox balance; Mucosal GSH and GSH dependent enzymes; Redox control of intestinal cell phenotypic transitions

Indexed keywords

CYSTEINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; I KAPPA B; MITOCHONDRIAL PROTEIN; THIOREDOXIN;

ANTIOXIDANT ACTIVITY; APOPTOSIS; BIOLOGY; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL PROLIFERATION; COMMENSAL; DIABETES MELLITUS; ENTERITIS; ENTEROPATHY; HUMAN; INTESTINE; INTESTINE CANCER; INTESTINE CELL; NONHUMAN; OXIDATION REDUCTION STATE; PHASE TRANSITION; REDOX STRESS; REVIEW; SIGNAL TRANSDUCTION;

CYSTEINE; CYSTINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HUMANS; INTESTINES; OXIDATION-REDUCTION; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; THIOREDOXINS;

EID: 80555127486     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.3109/10715762.2011.611509     Document Type: Review

References (237)

1. Lipkin M. Proliferation and differentiation of gastrointestinal cells. Physiol Rev 1973;53:891-915.
2. Cheng H. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. IV. Paneth cells. Am J Anat 1974;141:521-535.
3. Spradling A, Drummond-Barbosa D, Kai T. Stem cells fi nd their niche. Nature 2001;414:98-104.
4. Radtke F, Clevers H. Self-renewal and cancer of the gut: two sides of a coin. Science 2005;307:1904-1909. (Pubitemid 40404692)
5. Cheng H, Leblond CP. Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian Theory of the origin of the four epithelial cell types. Am J Anat 1974;141:537-561.
6. Drubin DG, Nelson WJ. Origins of cell polarity. Cell 1996;84:335-344. (Pubitemid 26058559)
7. Anderson JM, Van Itallie CM, Fanning AS. Setting up a selective barrier at the apical junction complex. Curr Opin Cell Biol 2004;16:140-145. (Pubitemid 38757290)
8. Semenza G. Anchoring and biosynthesis of stalked brush border membrane proteins: glycosidases and peptidases of enterocytes and renal tubuli. Annu Rev Cell Biol 1986;2:255-313.
9. Karam SM. Lineage commitment and maturation of epithelial cells in the gut. Front Biosci 1999;4:D286-D298.
10. Snoeck V, Goddeeris B, Cox E. The role of enterocytes in the intestinal barrier function and antigen uptake. Microbes Infect 2005;7:997-1004. (Pubitemid 40982667)
11. Neutra MR, Mantis NJ, Kraehenbuhl JP. Collaboration of epithelial cells with organized mucosal lymphoid tissues. Nat Immunol 2001;2:1004-1009. (Pubitemid 33069494)
12. Owen RL, Jones AL. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology 1974;66:189-203.
13. Jung C, Hugot JP, Barreau F. Peyer's Patches: The Immune Sensors of the Intestine. Int J Infl am 2010;2010:823710.
14. Neutra MR, Frey A, Kraehenbuhl JP. Epithelial M cells: gateways for mucosal infection and immunization. Cell 1996;86:345-348. (Pubitemid 26272074)
15. Jensen VB, Harty JT, Jones BD. Interactions of the invasive pathogens Salmonella typhimurium, Listeria monocytogenes, and Shigella fl exneri with M cells and murine Peyer's patches. Infect Immun 1998;66:3758-3766. (Pubitemid 28347834)
16. Corr SC, Gahan CC, Hill C. M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis. FEMS Immunol Med Microbiol 2008;52:2-12.
17. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfi de/glutathione couple. Free Radic Biol Med 2001;30: 1191-1212. (Pubitemid 32463931)
18. Kemp M, Go YM, Jones DP. Nonequilibrium thermodynamics of thiol/disulfi de redox systems: A perspective on redox systems biology. Free Radic Biol Med 2008;44:921-937.
19. Go YM, Jones DP. Redox compartmentalization in eukaryotic cells. Biochim Biophys Acta 2008;1780:1273-1290.
20. Hansen JM, Go YM, Jones DP. Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. Annu Rev Pharmacol Toxicol 2006;46:215-234. (Pubitemid 43271189)
21. Jones DP, Go YM. Redox compartmentalization and cellular stress. Diabetes Obes Metab 2010;12 Suppl 2:116-125.
22. Jones DP. Redefi ning oxidative stress. Antioxid Redox Signal 2006;8:1865-1879.
23. Sies H. Oxidative stress: Introductory remarks. In: Sies H, editor. Oxidative stress. London: Academic Press. 1985; p. 1-8.
24. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 2010;48: 749-762.
25. Meister A, Tate SS. Glutathione and related gamma-glutamyl compounds: biosynthesis and utilization. Annu Rev Biochem 1976;45:559-604.
26. Ballatori N, Krance SM, Marchan R, Hammond CL. Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology. Mol Aspects Med 2009;30: 13-28.
27. Hagen TM, Wierzbicka GT, Bowman BB, Aw TY, Jones DP. Fate of dietary glutathione: disposition in the gastrointestinal tract. Am J Physiol 1990;259:G530-G535. (Pubitemid 20340459)
28. Hagen TM, Aw TY, Jones DP. Glutathione uptake and protection against oxidative injury in isolated kidney cells. Kidney Int 1988;34:74-81.
29. Jocelyn PC, Kamminga A. The non-protein thiol of rat liver mitochondria. Biochim Biophys Acta 1974;343:356-362.
30. Schnellmann RG. Renal mitochondrial glutathione transport. Life Sci 1991;49:393-398.
31. Chen Z, Lash LH. Evidence for mitochondrial uptake of glutathione by dicarboxylate and 2-oxoglutarate carriers. J Pharmacol Exp Ther 1998;285:608-618. (Pubitemid 28237440)
32. Rebrin I, Sohal RS. Comparison of thiol redox state of mitochondria and homogenates of various tissues between two strains of mice with different longevities. Exp Gerontol 2004;39:1513-1519. (Pubitemid 39410551)
33. Koehler CM, Beverly KN, Leverich EP. Redox pathways of the mitochondrion. Antioxid Redox Signal 2006;8:813-822. (Pubitemid 44036499)
34. Herrmann JM, Riemer J. The intermembrane space of mitochondria. Antioxid Redox Signal 2010;13:1341-1358.
35. Ostergaard H, Tachibana C, Winther JR. Monitoring disulfi de bond formation in the eukaryotic cytosol. J Cell Biol 2004;166:337-345. (Pubitemid 39031237)
36. Bass R, Ruddock LW, Klappa P, Freedman RB. A major fraction of endoplasmic reticulum-located glutathione is present as mixed disulfi des with protein. J Biol Chem 2004;279:5257-5262. (Pubitemid 38220545)
37. Ho YF, Guenthner TM. Isolation of liver nuclei that retain functional trans-membrane transport. J Pharmacol Toxicol Methods 1997;38:163-168. (Pubitemid 28121353)
38. Markovic J, Borras C, Ortega A, Sastre J, Vina J, Pallardo FV. Glutathione is recruited into the nucleus in early phases of cell proliferation. J Biol Chem 2007;282:20416-20424. (Pubitemid 47099986)
39. Hansen JM, Zhang H, Jones DP. Mitochondrial thioredoxin-2 has a key role in determining tumor necrosis factoralpha-induced reactive oxygen species generation, NF-kappaB activation, and apoptosis. Toxicol Sci 2006;91:643-650. (Pubitemid 43827316)
40. Ahsan MK, Lekli I, Ray D, Yodoi J, Das DK. Redox regulation of cell survival by the thioredoxin superfamily: an implication of redox gene therapy in the heart. Antioxid Redox Signal 2009;11:2741-2758.
41. Conrad M, Jakupoglu C, Moreno SG, Lippl S, Banjac A, Schneider M, et al. Essential role for mitochondrial thioredoxin reductase in hematopoiesis, heart development, and heart function. Mol Cell Biol 2004;24:9414-9423. (Pubitemid 39391679)
42. Knoops B, Goemaere J, Van Der Eecken V, Declercq JP. Peroxiredoxin 5: Structure, mechanism and function of the mammalian atypical 2-Cys peroxiredoxin. Antioxid Redox Signal 2011;15:817-829.
43. Manevich Y, Sweitzer T, Pak JH, Feinstein SI, Muzykantov V, Fisher AB. 1-Cys peroxiredoxin overexpression protects cells against phospholipid peroxidation-mediated membrane damage. Proc Natl Acad Sci USA 2002;99:11599-11604. (Pubitemid 34994445)
44. Cox AG, Pearson AG, Pullar JM, Jonsson TJ, Lowther WT, Winterbourn CC, Hampton MB. Mitochondrial peroxiredoxin 3 is more resilient to hyperoxidation than cytoplasmic peroxiredoxins. Biochem J 2009;421:51-58.
45. Woo HA, Chae HZ, Hwang SC, Yang KS, Kang SW, Kim K, Rhee SG. Reversing the inactivation of peroxiredoxins caused by cysteine sulfi nic acid formation. Science 2003; 300:653-656. (Pubitemid 36520592)
46. Jonsson TJ, Lowther WT. The peroxiredoxin repair proteins. Subcell Biochem 2007;44:115-141.
47. Woo HA, Yim SH, Shin DH, Kang D, Yu DY, Rhee SG. Inactivation of peroxiredoxin I by phosphorylation allows localized H(2)O(2) accumulation for cell signaling. Cell 2010;140:517-528.
48. Blanco RA, Ziegler TR, Carlson BA, Cheng PY, Park Y, Cotsonis GA, et al. Diurnal variation in glutathione and cysteine redox states in human plasma. Am J Clin Nutr 2007;86:1016-1023. (Pubitemid 47538304)
49. Park Y, Ziegler TR, Gletsu-Miller N, Liang Y, Yu T, Accardi CJ, Jones DP. Postprandial cysteine/cystine redox potential in human plasma varies with meal content of sulfur amino acids. J Nutr 2010;140:760-765.
50. Dickinson DA, Forman HJ. Glutathione in defense and signaling: lessons from a small thiol. Ann N Y Acad Sci 2002;973:488-504. (Pubitemid 36131049)
51. Stipanuk MH. Sulfur amino acid metabolism: pathways for production and removal of homocysteine and cysteine. Annu Rev Nutr 2004;24:539-577. (Pubitemid 38938803)
52. Lash LH, Jones DP. Characteristics of cysteine uptake in intestinal basolateral membrane vesicles. Am J Physiol 1984; 247:G394-G401. (Pubitemid 15208224)
53. Moriarty-Craige SE, Jones DP. Extracellular thiols and thiol/disulfi de redox in metabolism. Annu Rev Nutr 2004;24: 481-509. (Pubitemid 38938801)
54. Aw TY. Biliary glutathione promotes the mucosal metabolism of luminal peroxidized lipids by rat small intestine in vivo. J Clin Invest 1994;94:1218-1225. (Pubitemid 24286466)
55. Aw TY, Williams MW. Intestinal absorption and lymphatic transport of peroxidized lipids in rats: effect of exogenous GSH. Am J Physiol 1992;263:G665-G672.
56. Aw TY, Williams MW, Gray L. Absorption and lymphatic transport of peroxidized lipids by rat small intestine in vivo: role of mucosal GSH. Am J Physiol 1992;262:G99-G106.
57. Aw TY, Wierzbicka G, Jones DP. Oral glutathione increases tissue glutathione in vivo. Chem Biol Interact 1991;80: 89-97.
58. Shan XQ, Aw TY, Jones DP. Glutathione-dependent protection against oxidative injury. Pharmacol Ther 1990;47: 61-71. (Pubitemid 20183308)
59. Hagen TM, Jones DP. Transepithelial transport of glutathione in vascularly perfused small intestine of rat. Am J Physiol 1987;252:G607-G613.
60. Martensson J, Jain A, Meister A. Glutathione is required for intestinal function. Proc Natl Acad Sci USA 1990; 87:1715-1719.
61. Vincenzini MT, Iantomasi T, Favilli F. Glutathione transport across intestinal brush-border membranes: effects of ions, pH, delta psi, and inhibitors. Biochim Biophys Acta 1989; 987:29-37. (Pubitemid 20008994)
62. Cao Y, Feng Z, Hoos A, Klimberg VS. Glutamine enhances gut glutathione production. JPEN J Parenter Enteral Nutr 1998;22:224-227. (Pubitemid 28307585)
63. Hagen TM, Wierzbicka GT, Sillau AH, Bowman BB, Jones DP. Bioavailability of dietary glutathione: effect on plasma concentration. Am J Physiol 1990;259:G524-G529. (Pubitemid 20340458)
64. Ballatori N, Rebbeor JF. Roles of MRP2 and oatp1 in hepatocellular export of reduced glutathione. Semin Liver Dis 1998;18:377-387. (Pubitemid 29011041)
65. Dahm LJ, Jones DP. Secretion of cysteine and glutathione from mucosa to lumen in rat small intestine. Am J Physiol 1994;267:G292-G300.
66. He M, Openo K, McCullough M, Jones DP. Total equivalent of reactive chemicals in 142 human food items is highly variable within and between major food groups. J Nutr 2004;134:1114-1119. (Pubitemid 38619948)
67. Jones DP, Coates RJ, Flagg EW, Eley JW, Block G, Greenberg RS, et al. Glutathione in foods listed in the National Cancer Institute's Health Habits and History Food Frequency Questionnaire. Nutr Cancer 1992;17:57-75.
68. Nkabyo YS, Gu LH, Jones DP, Ziegler TR. Thiol/disulfi de redox status is oxidized in plasma and small intestinal and colonic mucosa of rats with inadequate sulfur amino acid intake. J Nutr 2006;136:1242-1248.
69. Dahm LJ, Jones DP. Rat jejunum controls luminal thioldisulfi de redox. J Nutr 2000;130:2739-2745.
70. Snary D, Allen A, Pain RH. Structural studies on gastric mucoproteins: lowering of molecular weight after reduction with 2-mercaptoethanol. Biochem Biophys Res Commun 1970;40:844-851.
71. Hudson VM. New insights into the pathogenesis of cystic fi brosis: pivotal role of glutathione system dysfunction and implications for therapy. Treat Respir Med 2004;3: 353-363.
72. Bishop C, Hudson VM, Hilton SC, Wilde C. A pilot study of the effect of inhaled buffered reduced glutathione on the clinical status of patients with cystic fi brosis. Chest 2005; 127:308-317. (Pubitemid 41724591)
73. De Lisle RC, Roach E, Jansson K. Effects of laxative and N-acetylcysteine on mucus accumulation, bacterial load, transit, and infl ammation in the cystic fi brosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 2007; 293:G577-G584. (Pubitemid 47435389)
74. G arcia MA, Yang N, Quinton PM. Normal mouse intestinal mucus release requires cystic fi brosis transmembrane regulator-dependent bicarbonate secretion. J Clin Invest 2009; 119:2613-2622.
75. Quinton PM. Cystic fi brosis: impaired bicarbonate secretion and mucoviscidosis. Lancet 2008;372:415-417.
76. Samiec PS, Dahm LJ, Jones DP. Glutathione S-transferase in mucus of rat small intestine. Toxicol Sci 2000;54:52-59. (Pubitemid 30152455)
77. Ames BN. Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative diseases. Science 1983;221:1256-1264.
78. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009;390: 191-214.
79. Srigiridhar K, Nair KM, Subramanian R, Singotamu L. Oral repletion of iron induces free radical mediated alterations in the gastrointestinal tract of rat. Mol Cell Biochem 2001; 219:91-98. (Pubitemid 32331449)
80. Jin F, Frohman C, Thannhauser TW, Welch RM, Glahn RP. Effects of ascorbic acid, phytic acid and tannic acid on iron bioavailability from reconstituted ferritin measured by an in vitro digestion-Caco-2 cell model. Br J Nutr 2009;101: 972-981.
81. Espey MG, Chen P, Chalmers B, Drisko J, Sun AY, Levine M, Chen Q. Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer. Free Radic Biol Med 2011;50:1610-1619.
82. Fernandes AP, Holmgren A. Glutaredoxins: glutathionedependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid Redox Signal 2004;6:63-74. (Pubitemid 38063976)
83. Haunhorst P, Berndt C, Eitner S, Godoy JR, Lillig CH. Characterization of the human monothiol glutaredoxin 3 (PICOT) as iron-sulfur protein. Biochem Biophys Res Commun 2010;394:372-376.
84. Godoy JR, Funke M, Ackermann W, Haunhorst P, Oesteritz S, Capani F, et al. Redox atlas of the mouse Immunohistochemical detection of glutaredoxin-, peroxiredoxin-, and thioredoxin-family proteins in various tissues of the laboratory mouse. Biochim Biophys Acta 2011;1810:2-92.
85. Toppo S, Flohe L, Ursini F, Vanin S, Maiorino M. Catalytic mechanisms and specifi cities of glutathione peroxidases: variations of a basic scheme. Biochim Biophys Acta 2009; 1790:1486-1500.
86. Chu FF, Esworthy RS, Doroshow JH. Role of Se-dependent glutathione peroxidases in gastrointestinal infl ammation and cancer. Free Radic Biol Med 2004;36:1481-1495. (Pubitemid 38746557)
87. Chu FF, Esworthy RS, Ho YS, Bermeister M, Swiderek K, Elliott RW. Expression and chromosomal mapping of mouse Gpx2 gene encoding the gastrointestinal form of glutathione peroxidase, GPX-GI. Biomed Environ Sci 1997;10:156-162. (Pubitemid 127472075)
88. Chu FF, Doroshow JH, Esworthy RS. Expression, characterization, and tissue distribution of a new cellular seleniumdependent glutathione peroxidase, GSHPx-GI. J Biol Chem 1993;268:2571-2576. (Pubitemid 23057880)
89. Chu FF, Esworthy RS. The expression of an intestinal form of glutathione peroxidase (GSHPx-GI) in rat intestinal epithelium. Arch Biochem Biophys 1995;323:288-294.
90. Wingler K, Bocher M, Flohe L, Kollmus H, Brigelius-Flohe R. mRNA stability and selenocysteine insertion sequence effi ciency rank gastrointestinal glutathione peroxidase high in the hierarchy of selenoproteins. Eur J Biochem 1999;259: 149-157. (Pubitemid 29030830)
91. Tham DM, Whitin JC, Kim KK, Zhu SX, Cohen HJ. Expression of extracellular glutathione peroxidase in human and mouse gastrointestinal tract. Am J Physiol 1998;275: G1463-G1471.
92. Speckmann B, Bidmon HJ, Pinto A, Anlauf M, Sies H, Steinbrenner H. Induction of glutathione peroxidase 4 expression during enterocytic cell differentiation. J Biol Chem 2011;286:10764-10772.
93. Hoensch H, Peters WH, Roelofs HM, Kirch W. Expression of the glutathione enzyme system of human colon mucosa by localisation, gender and age. Curr Med Res Opin 2006; 22:1075-1083. (Pubitemid 44000728)
94. McIlwain CC, Townsend DM, Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006;25:1639-1648.
95. Pool-Zobel B, Veeriah S, Bohmer FD. Modulation of xenobiotic metabolising enzymes by anticarcinogens-focus on glutathione S-transferases and their role as targets of dietary chemoprevention in colorectal carcinogenesis. Mutat Res 2005;591:74-92. (Pubitemid 41656060)
96. Ebert MN, Klinder A, Peters WH, Schaferhenrich A, Sendt W, Scheele J, Pool-Zobel BL. Expression of glutathione S-transferases (GSTs) in human colon cells and inducibility of GSTM2 by butyrate. Carcinogenesis 2003;24: 1637-1644. (Pubitemid 37304668)
97. Gilbert HF. Molecular and cellular aspects of thiol-disulfi de exchange. Adv Enzymol Relat Areas Mol Biol 1990;63: 69-172.
98. Scharrer E, Senn E, Wolffram S. Stimulation of mucosal uptake of selenium from selenite by some thiols at various sites of rat intestine. Biol Trace Elem Res 1992;33: 109-120.
99. Jonas CR, Ziegler TR, Gu LH, Jones DP. Extracellular thiol/disulfi de redox state affects proliferation rate in a human colon carcinoma (Caco2) cell line. Free Radic Biol Med 2002;33:1499-1506. (Pubitemid 35351593)
100. Remond D, Buffi ere C, Pouyet C, Papet I, Dardevet D, Savary-Auzeloux I, et al. Cysteine fl uxes across the portaldrained viscera of enterally fed minipigs: effect of an acute intestinal infl ammation. Amino Acids 2011;40:543-552.
101. Van Klinken BJ, Einerhand AW, Buller HA, Dekker J. Strategic biochemical analysis of mucins. Anal Biochem 1998;265:103-116. (Pubitemid 28541799)
102. Fang Z, Yao K, Zhang X, Zhao S, Sun Z, Tian G, et al. Nutrition and health relevant regulation of intestinal sulfur amino acid metabolism. Amino Acids 2010;39:633-640.
103. Neil MW. The absorption of cystine and cysteine from rat small intestine. Biochem J 1959;71:118-124.
104. Bannai S. Transport of cystine and cysteine in mammalian cells. Biochim Biophys Acta 1984;779:289-306. (Pubitemid 14027591)
105. Mannery YO, Ziegler TR, Hao L, Shyntum Y, Jones DP. Characterization of apical and basal thiol-disulfi de redox regulation in human colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2010;299:G523-G530.
106. Go YM, Jones DP. Cysteine/cystine redox signaling in cardiovascular disease. Free Radic Biol Med 2011;50: 495-509.
107. Ookhtens M, Kaplowitz N. Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine. Semin Liver Dis 1998;18:313-329. (Pubitemid 29011037)
108. Riedijk MA, Stoll B, Chacko S, Schierbeek H, Sunehag AL, van Goudoever JB, Burrin DG. Methionine transmethylation and transsulfuration in the piglet gastrointestinal tract. Proc Natl Acad Sci USA 2007;104:3408-3413. (Pubitemid 46364172)
109. Gasdaska JR, Gasdaska PY, Gallegos A, Powis G. Human thioredoxin reductase gene localization to chromosomal position 12q23-q24.1 and mRNA distribution in human tissue. Genomics 1996;37:257-259. (Pubitemid 26360904)
110. Schroeder BO, Wu Z, Nuding S, Groscurth S, Marcinowski M, Beisner J, et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 2011;469:419-423.
111. Sido B, Giese T, Autschbach F, Lasitschka F, Braunstein J, Meuer SC. Potential role of thioredoxin in immune responses in intestinal lamina propria T lymphocytes. Eur J Immunol 2005;35:408-417. (Pubitemid 40331318)
112. Hooper LV, Gordon JI. Commensal host-bacterial relationships in the gut. Science 2001;292:1115-1118. (Pubitemid 32440925)
113. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr 2002;22:283-307. (Pubitemid 35221463)
114. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007;5:e177.
115. Vael C, Desager K. The importance of the development of the intestinal microbiota in infancy. Curr Opin Pediatr 2009;21:794-800.
116. Huycke MM, Gaskins HR. Commensal bacteria, redox stress, and colorectal cancer: mechanisms and models. Exp Biol Med (Maywood) 2004;229:586-597. (Pubitemid 38885671)
117. Martin FP, Sprenger N, Yap IK, Wang Y, Bibiloni R, Rochat F, et al. Panorganismal gut microbiome-host metabolic crosstalk. J Proteome Res 2009;8:2090-2105.
118. Martin FP, Wang Y, Yap IK, Sprenger N, Lindon JC, Rezzi S, et al. Topographical variation in murine intestinal metabolic profi les in relation to microbiome speciation and functional ecological activity. J Proteome Res 2009;8: 3464-3474.
119. Macfarlane GT, Gibson GR, Cummings JH. Comparison of fermentation reactions in different regions of the human colon. J Appl Bacteriol 1992;72:57-64.
120. Magee EA, Richardson CJ, Hughes R, Cummings JH. Contribution of dietary protein to sulfi de production in the large intestine: an in vitro and a controlled feeding study in humans. Am J Clin Nutr 2000;72:1488-1494.
121. Weisiger RA, Pinkus LM, Jakoby WB. Thiol S-methyltransferase: suggested role in detoxication of intestinal hydrogen sulfi de. Biochem Pharmacol 1980;29:2885-2887. (Pubitemid 10021171)
122. Leschelle X, Goubern M, Andriamihaja M, Blottiere HM, Couplan E, Gonzalez-Barroso MD, et al. Adaptative metabolic response of human colonic epithelial cells to the adverse effects of the luminal compound sulfi de. Biochim Biophys Acta 2005;1725:201-212. (Pubitemid 41253930)
123. Goubern M, Andriamihaja M, Nubel T, Blachier F, Bouillaud F. Sulfi de, the fi rst inorganic substrate for human cells. Faseb J 2007;21:1699-1706. (Pubitemid 46855615)
124. Lagoutte E, Mimoun S, Andriamihaja M, Chaumontet C, Blachier F, Bouillaud F.Oxidation of hydrogen sulfi de remains a priority in mammalian cells and causes reverse electron transfer in colonocytes. Biochim Biophys Acta 2010;1797:1500-1511.
125. Whiteman M, Armstrong JS, Chu SH, Jia-Ling S, Wong BS, Cheung NS, et al. The novel neuromodulator hydrogen sulfi de: an endogenous peroxynitrite ' scavenger ' ? J Neurochem 2004;90:765-768. (Pubitemid 38989409)
126. Kimura Y, Goto Y, Kimura H. Hydrogen sulfi de increases glutathione production and suppresses oxidative stress in mitochondria. Antioxid Redox Signal 2010;12:1-13.
127. Van Der Flier LG, Clevers H. Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 2009;71:241-260.
128. He XC, Zhang J, Tong WG, Tawfi k O, Ross J, Scoville DH, et al. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-beta-catenin signaling. Nat Genet 2004;36:1117-1121. (Pubitemid 41184475)
129. Scoville DH, Sato T, He XC, Li L. Current view: intestinal stem cells and signaling. Gastroenterology 2008;134:849-864. (Pubitemid 351312767)
130. Coant N, Ben Mkaddem S, Pedruzzi E, Guichard C, Treton X, Ducroc R, et al. NADPH oxidase 1 modulates WNT and NOTCH1 signaling to control the fate of proliferative progenitor cells in the colon. Mol Cell Biol 2010;30:2636-2650.
131. Aw TY. Intestinal glutathione: determinant of mucosal peroxide transport, metabolism, and oxidative susceptibility. Toxicol Appl Pharmacol 2005;204:320-328. (Pubitemid 40545234)
132. Jones DP. Redox potential of GSH/GSSG couple: assay and biological signifi cance. Methods Enzymol 2002;348: 93-112. (Pubitemid 41103102)
133. Nkabyo YS, Ziegler TR, Gu LH, Watson WH, Jones DP. Glutathione and thioredoxin redox during differentiation in human colon epithelial (Caco-2) cells. Am J Physiol Gastrointest Liver Physiol 2002;283:G1352-G1359. (Pubitemid 35351123)
134. Aw TY. Cellular redox: a modulator of intestinal epithelial cell proliferation. News Physiol Sci 2003;18:201-204. (Pubitemid 37356867)
135. Jonas CR, Gu LH, Nkabyo YS, Mannery YO, Avissar NE, Sax HC, et al. Glutamine and KGF each regulate extracellular thiol/disulfi de redox and enhance proliferation in Caco-2 cells. Am J Physiol Regul Integr Comp Physiol 2003;285:R1421-R1429. (Pubitemid 37464401)
136. Noda T, Iwakiri R, Fujimoto K, Rhoads CA, Aw TY. Exogenous cysteine and cystine promote cell proliferation in CaCo-2 cells. Cell Prolif 2002;35:117-129. (Pubitemid 34603858)
137. Anderson CL, Iyer SS, Ziegler TR, Jones DP. Control of extracellular cysteine/cystine redox state by HT-29 cells is independent of cellular glutathione. Am J Physiol Regul Integr Comp Physiol 2007;293:R1069-R1075. (Pubitemid 47358926)
138. Sun Y, Rigas B. The thioredoxin system mediates redoxinduced cell death in human colon cancer cells: implications for the mechanism of action of anticancer agents. Cancer Res 2008;68:8269-8277.
139. Gotoh Y, Noda T, Iwakiri R, Fujimoto K, Rhoads CA, Aw TY. Lipid peroxide-induced redox imbalance differentially mediates CaCo-2 cell proliferation and growth arrest. Cell Prolif 2002;35:221-235. (Pubitemid 34985157)
140. Wang TG, Gotoh Y, Jennings MH, Rhoads CA, Aw TY. Lipid hydroperoxide-induced apoptosis in human colonic CaCo-2 cells is associated with an early loss of cellular redox balance. Faseb J 2000;14:1567-1576. (Pubitemid 30636561)
141. Noda T, Iwakiri R, Fujimoto K, Aw TY. Induction of mild intracellular redox imbalance inhibits proliferation of CaCo-2 cells. Faseb J 2001;15:2131-2139. (Pubitemid 32927930)
142. Tabata K, Johnson LR. Ornithine decarboxylase and mucosal growth in response to feeding. Am J Physiol 1986;251: G270-G274.
143. Iwakiri R, Gotoh Y, Noda T, Sugihara H, Fujimoto K, Fuseler J, Aw TY. Programmed cell death in rat intestine: effect of feeding and fasting. Scand J Gastroenterol 2001;36: 39-47. (Pubitemid 32147180)
144. Tsunada S, Iwakiri R, Fujimoto K, Aw TY. Chronic lipid hydroperoxide stress suppresses mucosal proliferation in rat intestine: potentiation of ornithine decarboxylase activity by epidermal growth factor. Dig Dis Sci 2003;48:2333-2341. (Pubitemid 38021739)
145. Tsunada S, Iwakiri R, Noda T, Fujimoto K, Fuseler J, Rhoads CA, Aw TY. Chronic exposure to subtoxic levels of peroxidized lipids suppresses mucosal cell turnover in rat small intestine and reversal by glutathione. Dig Dis Sci 2003;48:210-222. (Pubitemid 36232785)
146. Nkabyo YS, Go YM, Ziegler TR, Jones DP. Extracellular cysteine/cystine redox regulates the p44/p42 MAPK pathway by metalloproteinase-dependent epidermal growth factor receptor signaling. Am J Physiol Gastrointest Liver Physiol 2005;289:G70-G78. (Pubitemid 40944225)
147. Tian J, Washizawa N, Gu LH, Levin MS, Wang L, Rubin DC, et al. Stimulation of colonic mucosal growth associated with oxidized redox status in rats. Am J Physiol Regul Integr Comp Physiol 2007;292:R1081-R1091. (Pubitemid 46377071)
148. Tian J, Washizawa N, Gu LH, Levin MS, Wang L, Rubin DC, et al. Local glutathione redox status does not regulate ileal mucosal growth after massive small bowel resection in rats. J Nutr 2007;137:320-325. (Pubitemid 46213443)
149. Shyntum Y, Iyer SS, Tian J, Hao L, Mannery YO, Jones DP, Ziegler TR. Dietary sulfur amino acid supplementation reduces small bowel thiol/disulfi de redox state and stimulates ileal mucosal growth after massive small bowel resection in rats. J Nutr 2009;139:2272-2278.
150. Knoll N, Ruhe C, Veeriah S, Sauer J, Glei M, Gallagher EP, Pool-Zobel BL. Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate. Toxicol Sci 2005;86:27-35. (Pubitemid 41511346)
151. Orihuela D, Meichtry V, Pregi N, Pizarro M. Short-term oral exposure to aluminium decreases glutathione intestinal levels and changes enzyme activities involved in its metabolism. J Inorg Biochem 2005;99:1871-1878. (Pubitemid 41253776)
152. Lash LH, Hagen TM, Jones DP. Exogenous glutathione protects intestinal epithelial cells from oxidative injury. Proc Natl Acad Sci USA 1986;83:4641-4645. (Pubitemid 16075457)
153. Aw TY, Rhoads CA. Glucose regulation of hydroperoxide metabolism in rat intestinal cells. Stimulation of reduced nicotinamide adenine dinucleotide phosphate supply. J Clin Invest 1994;94:2426-2434.
154. Circu ML, Moyer MP, Harrison L, Aw TY. Contribution of glutathione status to oxidant-induced mitochondrial DNA damage in colonic epithelial cells. Free Radic Biol Med 2009;47:1190-1198.
155. Circu ML, Rodriguez C, Maloney R, Moyer MP, Aw TY. Contribution of mitochondrial GSH transport to matrix GSH status and colonic epithelial cell apoptosis. Free Radic Biol Med 2008;44:768-778. (Pubitemid 351220966)
156. Circu ML, Stringer S, Rhoads CA, Moyer MP, Aw TY. The role of GSH effl ux in staurosporine-induced apoptosis in colonic epithelial cells. Biochem Pharmacol 2009;77: 76-85.
157. Pias EK, Aw TY. Early redox imbalance mediates hydroperoxide-induced apoptosis in mitotic competent undifferentiated PC-12 cells. Cell Death Differ 2002;9:1007-1016. (Pubitemid 35023615)
158. Pias EK, Aw TY. Apoptosis in mitotic competent undifferentiated cells is induced by cellular redox imbalance independent of reactive oxygen species production. Faseb J 2002;16:781-790. (Pubitemid 34615126)
159. Circu ML, Aw TY. Glutathione and apoptosis. Free Radic Res 2008;42:689-706.
160. Garcia-Ruiz C, Fernandez-Checa JC. Mitochondrial glutathione: hepatocellular survival-death switch. J Gastroenterol Hepatol 2006;21 Suppl 3:S3-S6. (Pubitemid 44266539)
161. Aon MA, Cortassa S, Maack C, O'Rourke B. Sequential opening of mitochondrial ion channels as a function of glutathione redox thiol status. J Biol Chem 2007;282: 21889-21900. (Pubitemid 47195754)
162. Kamga CK, Zhang SX, Wang Y. Dicarboxylate carriermediated glutathione transport is essential for reactive oxygen species homeostasis and normal respiration in rat brain mitochondria. Am J Physiol Cell Physiol 2010;299:C497-C505.
163. Caballero F, Fernandez A, Matias N, Martinez L, Fucho R, Elena M, et al. Specifi c contribution of methionine and choline in nutritional nonalcoholic steatohepatitis: impact on mitochondrial S-adenosyl-L-methionine and glutathione. J Biol Chem 2010;285:18528-18536.
164. Armstrong JS, Jones DP. Glutathione depletion enforces the mitochondrial permeability transition and causes cell death in Bcl-2 overexpressing HL60 cells. Faseb J 2002; 16:1263-1265.
165. Coll O, Colell A, Garcia-Ruiz C, Kaplowitz N, Fernandez-Checa JC. Sensitivity of the 2-oxoglutarate carrier to alcohol intake contributes to mitochondrial glutathione depletion. Hepatology 2003;38:692-702. (Pubitemid 37052156)
166. Wadey AL, Muyderman H, Kwek PT, Sims NR. Mitochondrial glutathione uptake: characterization in isolated brain mitochondria and astrocytes in culture. J Neurochem 2009;109 Suppl 1:101-108.
167. Fernandez A, Colell A, Garcia-Ruiz C, Fernandez-Checa JC. Cholesterol and sphingolipids in alcohol-induced liver injury. J Gastroenterol Hepatol 2008;23 Suppl 1:S9-S15. (Pubitemid 351389027)
168. Colell A, Fernandez A, Fernandez-Checa JC. Mitochondria, cholesterol and amyloid beta peptide: a dangerous trio in Alzheimer disease. J Bioenerg Biomembr 2009;41:417-423.
169. Fernandez-Checa JC, Ookhtens M, Kaplowitz N. Effect of chronic ethanol feeding on rat hepatocytic glutathione. Compartmentation, effl ux, and response to incubation with ethanol. J Clin Invest 1987;80:57-62. (Pubitemid 17097516)
170. Colell A, Garcia-Ruiz C, Miranda M, Ardite E, Mari M, Morales A, et al. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 1998;115:1541-1551. (Pubitemid 28546006)
171. Fernandez A, Llacuna L, Fernandez-Checa JC, Colell A. Mitochondrial cholesterol loading exacerbates amyloid beta peptide-induced infl ammation and neurotoxicity. J Neurosci 2009;29:6394-6405.
172. Lash LH, Putt DA, Matherly LH. Protection of NRK-52E cells, a rat renal proximal tubular cell line, from chemicalinduced apoptosis by overexpression of a mitochondrial glutathione transporter. J Pharmacol Exp Ther 2002;303: 476-486. (Pubitemid 35231216)
173. Xu F, Putt DA, Matherly LH, Lash LH. Modulation of expression of rat mitochondrial 2-oxoglutarate carrier in NRK-52E cells alters mitochondrial transport and accumulation of glutathione and susceptibility to chemically induced apoptosis. J Pharmacol Exp Ther 2006;316:1175-1186. (Pubitemid 43345292)
174. Martensson J, Lai JC, Meister A. High-affi nity transport of glutathione is part of a multicomponent system essential for mitochondrial function. Proc Natl Acad Sci USA 1990; 87:7185-7189.
175. Chen Z, Putt DA, Lash LH. Enrichment and functional reconstitution of glutathione transport activity from rabbit kidney mitochondria: further evidence for the role of the dicarboxylate and 2-oxoglutarate carriers in mitochondrial glutathione transport. Arch Biochem Biophys 2000;373: 193-202. (Pubitemid 30046504)
176. Benipal B, Lash LH. Infl uence of renal compensatory hypertrophy on mitochondrial energetics and redox status. Biochem Pharmacol 2011;81:295-303.
177. Garcia J, Han D, Sancheti H, Yap LP, Kaplowitz N, Cadenas E. Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates. J Biol Chem 2010;285:39646-39654.
178. Circu ML, Maloney RE, Aw TY. Disruption of pyridine nucleotide redox status during oxidative challenge at normal and low-glucose states: implications for cellular adenosine triphosphate, mitochondrial respiratory activity, and reducing capacity in colon epithelial cells. Antioxid Redox Signal 2011;14:2151-2162.
179. Arndt H, Palitzsch KD, Anderson DC, Rusche J, Grisham MB, Granger DN. Leucocyte-endothelial cell adhesion in a model of intestinal infl ammation. Gut 1995;37:374-379.
180. Yamada T, Grisham MB. Role of neutrophil-derived oxidants in the pathogenesis of intestinal infl ammation. Klin Wochenschr 1991;69:988-994.
181. Iantomasi T, Marraccini P, Favilli F, Vincenzini MT, Ferretti P, Tonelli F. Glutathione metabolism in Crohn's disease. Biochem Med Metab Biol 1994;53:87-91.
182. Holmes EW, Yong SL, Eiznhamer D, Keshavarzian A. Glutathione content of colonic mucosa: evidence for oxidative damage in active ulcerative colitis. Dig Dis Sci 1998;43:1088-1095. (Pubitemid 28211471)
183. Sido B, Hack V, Hochlehnert A, Lipps H, Herfarth C, Droge W. Impairment of intestinal glutathione synthesis in patients with infl ammatory bowel disease. Gut 1998;42:485-492. (Pubitemid 28186563)
184. Karp SM, Koch TR. Oxidative stress and antioxidants in infl ammatory bowel disease. Dis Mon 2006;52:199-207. (Pubitemid 43975094)
185. Tsunada S, Iwakiri R, Ootani H, Aw TY, Fujimoto K. Redox imbalance in the colonic mucosa of ulcerative colitis. Scand J Gastroenterol 2003;38:1002-1003. (Pubitemid 37153632)
186. Millar AD, Rampton DS, Chander CL, Claxson AW, Blades S, Coumbe A, et al. Evaluating the antioxidant potential of new treatments for infl ammatory bowel disease using a rat model of colitis. Gut 1996;39:407-415. (Pubitemid 26338530)
187. Schepens MA, Vink C, Schonewille AJ, Roelofs HM, Brummer RJ, Van Der Meer R, Bovee-Oudenhoven IM. Supplemental antioxidants do not ameliorate colitis development in HLA-B27 transgenic rats despite extremely low glutathione levels in colonic mucosa. Infl amm Bowel Dis 2010; in press
188. Fiocchi C. Infl ammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205. (Pubitemid 28307304)
189. Qiao L, Schurmann G, Meuer SC, Wallich R, Schirren A, Autschbach F. Regulation of T cell reactivities by intestinal mucosa. Adv Exp Med Biol 1995;371A:31-34.
190. Sido B, Lasitschka F, Giese T, Gassler N, Funke B, Schroder-Braunstein J, et al. A prominent role for mucosal cystine/cysteine metabolism in intestinal immunoregulation. Gastroenterology 2008;134:179-191. (Pubitemid 350309332)
191. Yan Z, Banerjee R. Redox remodeling as an immunoregulatory strategy. Biochemistry 2010;49:1059-1066.
192. Sido B, Braunstein J, Breitkreutz R, Herfarth C, Meuer SC. Thiol-mediated redox regulation of intestinal lamina propria T lymphocytes. J Exp Med 2000;192:907-912.
193. Reyes BM, Danese S, Sans M, Fiocchi C, Levine AD. Redox equilibrium in mucosal T cells tunes the intestinal TCR signaling threshold. J Immunol 2005;175:2158-2166. (Pubitemid 41113821)
194. Ellis RD, Goodlad JR, Limb GA, Powell JJ, Thompson RP, Punchard NA. Activation of nuclear factor kappa B in Crohn's disease. Infl amm Res 1998;47:440-445. (Pubitemid 28532654)
195. Schreiber S, Nikolaus S, Hampe J. Activation of nuclear factor kappa B infl ammatory bowel disease. Gut 1998;42: 477-484. (Pubitemid 28186562)
196. Pasparakis M. IKK/NF-kappaB signaling in intestinal epithelial cells controls immune homeostasis in the gut. Mucosal Immunol 1 Suppl 2008;1:S54-S57.
197. Pasparakis M. Regulation of tissue homeostasis by NF-kappaB signalling: implications for infl ammatory diseases. Nat Rev Immunol 2009;9:778-788.
198. Spehlmann ME, Eckmann L. Nuclear factor-kappa B in intestinal protection and destruction. Curr Opin Gastroenterol 2009;25:92-99.
199. Eckmann L, Nebelsiek T, Fingerle AA, Dann SM, Mages J, Lang R, et al. Opposing functions of IKKbeta during acute and chronic intestinal infl ammation. Proc Natl Acad Sci USA 2008;105:15058-15063.
200. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S, et al. Epithelial NEMO links innate immunity to chronic intestinal infl ammation. Nature 2007;446:557-561. (Pubitemid 46514732)
201. Brigelius-Flohe R, Flohe L. Basic Principles and Emerging Concepts in the Redox Control of Transcription Factors. Antioxid Redox Signal 2011; in press.
202. Morgan MJ, Liu ZG. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Res 2011;21:103-115.
203. Klatt P, Lamas S. Regulation of protein function by Sglutathiolation in response to oxidative and nitrosative stress. Eur J Biochem 2000;267:4928-4944. (Pubitemid 30641289)
204. Ando K, Hirao S, Kabe Y, Ogura Y, Sato I, Yamaguchi Y, et al. A new APE1/Ref-1-dependent pathway leading to reduction of NF-kappaB and AP-1, and activation of their DNAbinding activity. Nucleic Acids Res 2008;36:4327-4336.
205. Kabe Y, Ando K, Hirao S, Yoshida M, Handa H. Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 2005;7:395-403. (Pubitemid 40279807)
206. Kumar A, Wu H, Collier-Hyams LS, Hansen JM, Li T, Yamoah K, et al. Commensal bacteria modulate cullindependent signaling via generation of reactive oxygen species. Embo J 2007;26:4457-4466. (Pubitemid 350036625)
207. Kumar A, Wu H, Collier-Hyams LS, Kwon YM, Hanson JM, Neish AS. The bacterial fermentation product butyrate infl uences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation. J Immunol 2009; 182:538-546.
208. Swanson PA 2nd, Kumar A, Samarin S, Vijay-Kumar M, Kundu K, Murthy N, et al. Enteric commensal bacteria potentiate epithelial restitution via reactive oxygen speciesmediated inactivation of focal adhesion kinase phosphatases. Proc Natl Acad Sci USA 2011.
209. Ghosh S, Dai C, Brown K, Rajendiran E, Makarenko S, Baker J, et al. Colonic microbiota alters host susceptibility to infectious colitis by modulating infl ammation, redox status and ion transporter gene expression. Am J Physiol Gastrointest Liver Physiol 2011;
210. Ott SJ, Musfeldt M, Wenderoth DF, Hampe J, Brant O, Folsch UR, et al. Reduction in diversity of the colonic mucosa associated bacterial microfl ora in patients with active infl ammatory bowel disease. Gut 2004;53:685-693. (Pubitemid 38561447)
211. Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Adrio JL, et al. Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic infl ammation in the TNBS model of rat colitis. Int J Colorectal Dis 2006; 21:737-746. (Pubitemid 44524027)
212. Peran L, Camuesco D, Comalada M, Nieto A, Concha A, Diaz-Ropero MP, et al. Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis. World J Gastroenterol 2005;11:5185-5192. (Pubitemid 41410337)
213. Chen LW, Chang WJ, Chen PH, Liu WC, Hsu CM. TLR ligand decreases mesenteric ischemia and reperfusion injuryinduced gut damage through TNF-alpha signaling. Shock 2008;30:563-570.
214. Wang Y, Rickman BH, Poutahidis T, Schlieper K, Jackson EA, Erdman SE, et al. c-Rel is essential for the development of innate and T cell-induced colitis. J Immunol 2008; 180:8118-8125.
215. Planson AG, Palais G, Abbas K, Gerard M, Couvelard L, Delaunay A, et al. Sulfi redoxin protects mice from lipopolysaccharide-induced endotoxic shock. Antioxid Redox Signal 2011;14:2071-2080.
216. Li L, Shoji W, Takano H, Nishimura N, Aoki Y, Takahashi R, et al. Increased susceptibility of MER5 (peroxiredoxin III) knockout mice to LPS-induced oxidative stress. Biochem Biophys Res Commun 2007;355:715-721. (Pubitemid 46330210)
217. Yang CS, Lee DS, Song CH, An SJ, Li S, Kim JM, et al. Roles of peroxiredoxin II in the regulation of proinfl ammatory responses to LPS and protection against endotoxininduced lethal shock. J Exp Med 2007;204:583-594. (Pubitemid 46457081)
218. Kong X, Thimmulappa R, Kombairaju P, Biswal S. NADPH oxidase-dependent reactive oxygen species mediate amplifi ed TLR4 signaling and sepsis-induced mortality in Nrf2-defi cient mice. J Immunol 2010;185:569-577.
219. Victor VM, Rocha M, De la Fuente M. Immune cells: free radicals and antioxidants in sepsis. Int Immunopharmacol 2004;4:327-347. (Pubitemid 38375967)
220. Mistry N, Bevan RJ, Cooke MS, Evans MD, Halligan EP, Lowes DA, et al. Antiserum detection of reactive carbonyl species-modifi ed DNA in human colonocytes. Free Radic Res 2008;42:344-353.
221. Storz P. Reactive oxygen species in tumor progression. Front Biosci 2005;10:1881-1896. (Pubitemid 40529044)
222. Brigelius-Flohe R, Kipp A. Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta 2009;1790:1555-1568.
223. Powis G, Mustacich D, Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic Biol Med 2000;29:312-322.
224. Florian S, Wingler K, Schmehl K, Jacobasch G, Kreuzer OJ, Meyerhof W, Brigelius-Flohe R. Cellular and subcellular localization of gastrointestinal glutathione peroxidase in normal and malignant human intestinal tissue. Free Radic Res 2001;35:655-663. (Pubitemid 34065657)
225. M urawaki Y, Tsuchiya H, Kanbe T, Harada K, Yashima K, Nozaka K, et al. Aberrant expression of selenoproteins in the progression of colorectal cancer. Cancer Lett 2008; 259:218-230. (Pubitemid 350258671)
226. Esworthy RS, Aranda R, Martin MG, Doroshow JH, Binder SW, Chu FF. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am J Physiol Gastrointest Liver Physiol 2001;281:G848-G855.
227. Florian S, Krehl S, Loewinger M, Kipp A, Banning A, Esworthy S, et al. Loss of GPx2 increases apoptosis, mitosis, and GPx1 expression in the intestine of mice. Free Radic Biol Med 2010;49:1694-1702.
228. Chu FF, Esworthy RS, Chu PG, Longmate JA, Huycke MM, Wilczynski S, Doroshow JH. Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res 2004;64:962-968. (Pubitemid 38176898)
229. Berggren M, Gallegos A, Gasdaska JR, Gasdaska PY, Warneke J, Powis G. Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia. Anticancer Res 1996;16:3459-3466. (Pubitemid 27084998)
230. Raffel J, Bhattacharyya AK, Gallegos A, Cui H, Einspahr JG, Alberts DS, Powis G. Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. J Lab Clin Med 2003;142:46-51. (Pubitemid 36934520)
231. Ohayon A, Babichev Y, Galperin M, Altman A, Isakov N. Widespread expression of PICOT in mouse and human tissues with predominant localization to epithelium. J Histochem Cytochem 2010;58:799-806.
232. Cha MK, Kim IH. Preferential overexpression of glutaredoxin3 in human colon and lung carcinoma. Cancer Epidemiol 2009;33:281-287.
233. Qu Y, Wang J, Ray PS, Guo H, Huang J, Shin-Sim M, et al. Thioredoxin-like 2 regulates human cancer cell growth and metastasis via redox homeostasis and NF-kappaB signaling. J Clin Invest 2011;121:212-225.
234. Tashima K, Fujita A, Takeuchi K. Aggravation of ischemia/reperfusion- induced gastric lesions in streptozotocin-diabetic rats. Life Sci 2000;67:1707-1718.
235. Iwakiri R, Rhoads CA, Aw TY. Determinants of hydroperoxide detoxifi cation in diabetic rat intestine: effect of insulin and fasting on the glutathione redox cycle. Metabolism 1995;44:1462-1468. (Pubitemid 26082538)
236. Tunali S, Yanardag R. Effect of vanadyl sulfate on the status of lipid parameters and on stomach and spleen tissues of streptozotocin-induced diabetic rats. Pharmacol Res 2006; 53:271-277. (Pubitemid 43247540)
237. Goldin E, Ardite E, Elizalde JI, Odriozola A, Panes J, Pique JM, Fernandez-Checa JC. Gastric mucosal damage in experimental diabetes in rats: role of endogenous glutathione. Gastroenterology 1997;112:855-863. (Pubitemid 27113811)